尿路結石症管理デバイス市場の2030年までの予測：製品別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、尿路結石症管理デバイスの世界市場は2023年に16億8,000万米ドルを占め、予測期間中にCAGR 6.9％で成長し、2030年には26億9,000万米ドルに達すると予測されています。

尿路結石症とは、泌尿器系に結石ができることを指します。尿路結石症管理装置は、腎臓結石や尿路内結石を含む尿路結石の診断、治療、管理に使用される専門的なツールや機器です。これらの機器は、低侵襲治療において重要な役割を果たし、患者の不快感を軽減し、回復時間を短縮し、尿路結石症に苦しむ人々の転帰を改善します。

欧州泌尿器科学会によると、尿路結石の有病率は1％～20％です。腎結石は、カナダ、スウェーデン、米国などの先進国ではかなり多く（10％以上）みられます。

尿路結石の有病率の上昇

世界中で腎結石や尿路結石の発生率が上昇していることを特徴とする尿路結石の有病率の上昇は、尿路結石症管理デバイス市場の重要な促進要因となっています。ライフスタイルの変化、食習慣、不十分な水分補給などの要因が、尿路結石の発生を増加させる一因となっています。このような症例の急増により、効果的な管理と治療が必要となり、尿石症管理デバイスの需要を煽っています。有病率が増加の一途をたどる中、結石破砕機、尿管鏡、結石回収ツールなどの高度な機器に対するニーズが高まっており、革新的なソリューションが市場を牽引しています。

高い治療費

外科的処置、医療機器、フォローアップケアなど、尿路結石症管理に関連する費用は高額になる可能性があります。こうした高額な費用のために、特に経済的に余裕のない患者や保険適用が不十分な患者にとっては、高度な治療法や医療機器へのアクセスが制限されます。経済的負担は、先進的な治療法を選択することを躊躇させ、その導入に影響を与え、市場成長の妨げとなっています。

低侵襲治療への需要の高まり

術後の痛みの軽減、入院期間の短縮、回復時間の短縮、従来の手術法に比べて合併症のリスクが低いなど、いくつかの利点があるため、患者はますます低侵襲治療を好むようになっています。この動向により、尿管鏡、レーザー結石破砕、衝撃波結石破砕などの低侵襲技術をサポートする尿路結石症管理装置の需要が急増しています。さらに、これらの装置は、周辺組織への外傷を最小限に抑えながら、結石を正確に狙い撃ちすることを可能にします。したがって、市場成長に対する需要が高まっています。

感染のリスク

尿管ステントや結石破砕装置などの尿路結石症管理デバイスを使用する侵襲的な処置は、感染の可能性を高める。器具の滅菌が不十分であったり、器具を長時間留置したり、介入を繰り返したりすると、尿路感染症や全身感染症につながる可能性があります。これらの感染症は合併症を引き起こし、入院期間を長引かせ、追加治療が必要となり、患者の健康転帰に影響を与えます。その結果、市場の需要を妨げることになります。

COVID-19の影響

COVID-19のパンデミックは、流通チャネルの混乱を引き起こし、企業や金融市場への財務的影響を通じています。障害により、さまざまな小規模病院や高齢者住宅が一時閉鎖を余儀なくされました。さらに、外来診療の予約に遅れが生じ、電話診療やバーチャル診療の需要が高まった。麻酔や処置の枠、病院内のベッド、医療従事者の不在は、大きな治療の滞りを招き、世界の尿路結石管理装置市場に悪影響を及ぼしました。

予測期間中、尿管内視鏡セグメントが最大になる見込み

尿管内視鏡セグメントが最大のシェアを占めると推定されます。尿管内視鏡は、小型カメラと光ファイバー技術を搭載した柔軟または半剛性の器具で構成され、泌尿器科医が尿管または腎臓内の結石を視覚化してアクセスできるようにします。尿管内を正確にナビゲーションし、結石の破砕、回収、レーザー結石破砕などの処置を可能にします。さらに、尿管内視鏡は侵襲性の低い介入において極めて重要な役割を果たし、患者の不快感を軽減し、回復時間を短縮し、効果的な結石管理に貢献することで、尿路結石症治療の展望を形成しています。

予測期間中、CAGRが最も高いのは病院セグメントです。

病院セグメントは予測期間中に有利な成長を遂げると予測されています。病院は、尿路結石症例の診断、治療、管理の主要なセンターとして機能しています。これらの施設では、砕石器、尿管鏡、結石回収器具、ステント、画像診断装置など、さまざまな尿路結石症管理デバイスが利用されています。病院では、泌尿器科的処置や手術を包括的に行い、尿路結石症患者のために入院および外来サービスを提供しています。このセグメントは、大規模な学術医療センターから小規模な地域病院まで、多様な病院環境を包含しており、これらすべてが、効果的な患者ケアの追求における尿路結石症管理機器の採用と活用に貢献しています。

最大のシェアを占める地域

アジア太平洋地域は、尿路結石症の有病率の上昇、ヘルスケア支出の増加、技術の進歩、高齢者人口の増加により、推定期間中に最大の市場シェアを占めました。さらに、ヘルスケアインフラの改善、医療施設へのアクセスの向上、尿路結石症治療の選択肢に関する認知度の拡大が、これらの機器の採用に拍車をかけています。アジア太平洋市場は、同地域の尿路結石症患者の進化するニーズに応えることを目指すメーカーやプロバイダーにとって、有利な機会を提供しています。

CAGRが最も高い地域：

北米は、低侵襲治療への嗜好、強力な研究開発活動、有利な償還政策により、予測期間中に収益性の高い成長が見込まれます。米国とカナダを含むこの地域は、強固なヘルスケアインフラを誇り、医療費が高く、泌尿器科の技術革新に力を入れています。さらに、患者中心の治療と技術の進歩に重点を置くようになり、主要な市場プレーヤーが存在することから、北米は最先端の尿路結石症治療ソリューションの主要拠点となっています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の尿路結石症管理デバイス市場：製品別

• 衝撃波砕石器
  • 体内
    • 超音波
    • レーザ
    • 空気圧
  • 体外
• 尿管腎鏡
  • リジッド
  • フレキシブル
  • セミリジッド

第6章 世界の尿路結石症管理デバイス市場：エンドユーザー別

• クリニックと外来治療センター
• 病院
• その他のエンドユーザー

第7章 世界の尿路結石症管理デバイス市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第8章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイル

• Olympus
• Boston Scientific
• Karl Storz
• Siemens Medical Solutions
• Richard Wolf
• Cook Medical
• Dornier
• Elmed
• MTS Medical
• Direxgroup
• Cybersonics
• Allengers
• BD
• DirexGroup
• CONMED Corporation
• Potent Medical
• HealthTronics, Inc

List of Tables

• Table 1 Global Urolithiasis Management Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 4 Global Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 5 Global Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 6 Global Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 7 Global Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 8 Global Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 9 Global Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 10 Global Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 11 Global Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 12 Global Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 13 Global Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 14 North America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 15 North America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 16 North America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 17 North America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 18 North America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 19 North America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 20 North America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 21 North America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 22 North America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 23 North America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 24 North America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 25 North America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 26 North America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 27 Europe Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 28 Europe Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 29 Europe Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 30 Europe Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 31 Europe Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 32 Europe Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 33 Europe Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 34 Europe Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 35 Europe Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 36 Europe Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 37 Europe Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 38 Europe Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 39 Europe Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 40 Asia Pacific Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 41 Asia Pacific Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 42 Asia Pacific Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 43 Asia Pacific Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 44 Asia Pacific Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 45 Asia Pacific Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 46 Asia Pacific Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 47 Asia Pacific Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 48 Asia Pacific Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 49 Asia Pacific Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 50 Asia Pacific Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 51 Asia Pacific Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 52 Asia Pacific Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 53 South America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 54 South America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 55 South America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 56 South America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 57 South America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 58 South America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 59 South America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 60 South America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 61 South America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 62 South America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 63 South America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 64 South America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 65 South America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 66 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 67 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 68 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 69 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 70 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 71 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 72 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 73 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 74 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 75 Middle East & Africa Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 76 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 77 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 78 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Urolithiasis Management Devices Market is accounted for $1.68 billion in 2023 and is expected to reach $2.69 billion by 2030 growing at a CAGR of 6.9% during the forecast period. Urolithiasis refers to the development of stones in the urinary system. Urolithiasis Management Devices are specialized tools and equipment used in the diagnosis, treatment, and management of urinary stones, including kidney stones and stones within the urinary tract. These devices play a crucial role in minimally invasive treatments, reducing patient discomfort, shortening recovery times, and improving outcomes for individuals suffering from urolithiasis.

According to the European Association of Urology, the prevalence of urinary stones ranges from 1% up to 20%. Renal stones are substantially more common (>10%) in developed nations like Canada, Sweden, and the U.S.

Market Dynamics:

Driver:

Rising prevalence of urolithiasis

The escalating prevalence of urolithiasis, characterised by a rising incidence of kidney stones and urinary tract stones worldwide, serves as a significant driver in the Urolithiasis Management Devices Market. Lifestyle changes, dietary habits, and factors like inadequate hydration contribute to the increased occurrence of urolithiasis. This surge in cases necessitates effective management and treatment, fuelling the demand for urolithiasis management devices. As the prevalence continues to grow, there is a heightened need for advanced devices such as lithotripters, ureteroscopes, and stone retrieval tools, driving the market towards innovative solutions.

Restraint:

High treatment costs

The expenses associated with urolithiasis management, including surgical procedures, medical devices, and follow-up care, can be substantial. These high costs limit accessibility to advanced treatments and devices, particularly for patients with limited financial means or inadequate insurance coverage. The financial burden discourages some individuals from opting for advanced procedures, impacting their adoption and hindering market growth.

Opportunity:

Growing demand for minimally invasive procedures

Patients increasingly prefer minimally invasive treatments due to several advantages, including reduced post-operative pain, shorter hospital stays, quicker recovery times, and a lower risk of complications compared to traditional surgical methods. This trend has surged the demand for urolithiasis management devices that support minimally invasive techniques such as ureteroscopy, laser lithotripsy, and shockwave lithotripsy. Additionally, these devices enable precise targeting of stones while minimising trauma to surrounding tissues. Thus, there is an increasing demand for market growth.

Threat:

Risk of infection

Invasive procedures involving urolithiasis management devices, such as ureteral stents or lithotripsy tools, increase the susceptibility to infections. Improperly sterilised equipment, prolonged device placement, or repeated interventions may lead to urinary tract infections or systemic infections. These infections can cause complications, prolong hospital stays, and necessitate additional treatments, impacting patient health outcomes. As a result, it will hinder market demand.

Covid-19 Impact

The COVID-19 pandemic is causing disruptions in distribution channels and through its financial impact on firms and financial markets. Due to obstacles, various small hospitals and elderly housing units had to be temporarily closed. Additionally, there was a delay in the scheduling of appointments for outpatient clinics, which increased the demand for phone or virtual clinics. The absence of anaesthesia or procedural slots, in-hospital beds, and medical personnel resulted in a major treatment backlog, which had a negative impact on the worldwide urolithiasis management device market.

The ureterorenoscopes segment is expected to be the largest during the forecast period

The ureterorenoscopes segment is estimated to hold the largest share. Ureterorenoscopes consist of flexible or semi-rigid instruments equipped with miniature cameras and fibre-optic technology, allowing urologists to visualise and access stones in the ureter or kidney. They facilitate precise navigation through the urinary tract, enabling procedures like stone fragmentation, retrieval, or laser lithotripsy. Furthermore, ureterorenoscopes play a pivotal role in less invasive interventions, reducing patient discomfort, shortening recovery times, and contributing to effective stone management, thereby shaping the landscape of urolithiasis treatment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as primary centres for the diagnosis, treatment, and management of urolithiasis cases. Within these facilities, various urolithiasis management devices are utilized, including lithotripters, ureteroscopes, stone retrieval tools, stents, and imaging modalities. Hospitals provide a comprehensive range of urological procedures and surgeries, offering both inpatient and outpatient services for urolithiasis patients. The segment encompasses diverse hospital settings, from large academic medical centres to smaller community hospitals, all contributing to the adoption and utilisation of urolithiasis management devices in the quest for effective patient care.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the rising prevalence of urolithiasis, increasing healthcare expenditure, technological advancements, and a growing geriatric population. Moreover, improving healthcare infrastructure, greater accessibility to medical facilities, and expanding awareness about urolithiasis treatment options fuel the adoption of these devices. The Asia-Pacific market presents lucrative opportunities for manufacturers and providers aiming to cater to the evolving needs of urolithiasis patients in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period due to preference for minimally invasive procedures, strong research and development activities, and favourable reimbursement policies. The region, encompassing the United States and Canada, boasts a robust healthcare infrastructure, high healthcare expenditures, and a significant focus on technological innovations in urology. Moreover, the presence of key market players, along with a growing emphasis on patient-centric care and technological advancements, positions North America as a leading hub for cutting-edge urolithiasis treatment solutions.

Key players in the market

Some of the key players in the Urolithiasis Management Devices Market include Olympus, Boston Scientific, Karl Storz, Siemens Medical Solutions, Richard Wolf, Cook Medical, Dornier, Elmed, MTS Medical, Direxgroup, Cybersonics, Allengers, BD, DirexGroup, CONMED Corporation, Potent Medical , and HealthTronics, Inc.

Key Developments:

In July 2022, Calyxo announced the successful closure of its Series C investment round, securing USD 32.7 million. Based in California, Calyxo has developed the CVAC Aspiration system, designed to eliminate kidney stones without the need for surgery, utilizing irrigation and aspiration methods.

In March 2022, The FDA recognized Applaud Medical's Acoustic Enhancer technology as a breakthrough product. It is designed to break down calcium-based urinary stones that are obstructing or pose a significant risk of future hindrance, provided they are between 6mm and 20 mm in diameter.

Products Covered:

• Shock Wave Lithotripters
• Ureterorenoscopes

End Users Covered:

• Clinics and Ambulatory Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Urolithiasis Management Devices Market, By Product

• 5.1 Introduction
• 5.2 Shock Wave Lithotripters
  • 5.2.1 Intracorporeal
    • 5.2.1.1 Ultrasound
    • 5.2.1.2 Laser
    • 5.2.1.3 Pneumatic
  • 5.2.2 Extracorporea
• 5.3 Ureterorenoscopes
  • 5.3.1 Rigid
  • 5.3.2 Flexible
  • 5.3.3 Semi Rigid

6 Global Urolithiasis Management Devices Market, By End User

• 6.1 Introduction
• 6.2 Clinics and Ambulatory Care Centers
• 6.3 Hospitals
• 6.4 Other End Users

7 Global Urolithiasis Management Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Olympus
• 9.2 Boston Scientific
• 9.3 Karl Storz
• 9.4 Siemens Medical Solutions
• 9.5 Richard Wolf
• 9.6 Cook Medical
• 9.7 Dornier
• 9.8 Elmed
• 9.9 MTS Medical
• 9.10 Direxgroup
• 9.11 Cybersonics
• 9.12 Allengers
• 9.13 BD
• 9.14 DirexGroup
• 9.15 CONMED Corporation
• 9.16 Potent Medical
• 9.17 HealthTronics, Inc